Detalhe da pesquisa
1.
Profiling of syngeneic mouse HCC tumor models as a framework to understand anti-PD-1 sensitive tumor microenvironments.
Hepatology
; 77(5): 1566-1579, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35941803
2.
Development, Practice Patterns, and Early Clinical Outcomes of a Multidisciplinary Liver Cancer Clinic.
Cancer Control
; 28: 10732748211009945, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882707
3.
Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma with Intra-atrial Tumor Extension: Imaging Response and Oncologic Outcomes.
J Vasc Interv Radiol
; 32(8): 1203-1208.e1, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34332718
4.
Tumor and Systemic Immunomodulatory Effects of MEK Inhibition.
Curr Oncol Rep
; 23(2): 23, 2021 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33547983
5.
Reply: The Hepa 1-6 may not be suitable for use in hepatocellular carcinoma models to explore responses to drug therapy.
Hepatology
; 79(4): E125-E126, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147327
6.
Rapidly progressive metastatic cholangiocarcinoma in a postpartum patient with cystic fibrosis: a case report.
BMC Pulm Med
; 20(1): 298, 2020 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33198722
7.
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Hepatology
; 78(6): 1922-1965, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37199193
8.
Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors.
Am J Hematol
; 94(5): 563-574, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30790338
9.
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.
Br J Cancer
; 116(11): 1402-1407, 2017 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28441383
10.
Surgical Debulking for Refractory Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma.
Hepatology
; 74(5): 2899-2901, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34105830
11.
Tumor Mutational Burden and Response Rate to PD-1 Inhibition.
N Engl J Med
; 377(25): 2500-2501, 2017 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29262275
12.
Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies.
Acta Neuropathol
; 128(5): 679-89, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25107476
13.
Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma: A Review.
JAMA Oncol
; 10(3): 395-404, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37535375
14.
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma.
Nat Rev Clin Oncol
; 21(4): 294-311, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38424197
15.
Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy: an evaluation of volumetric imaging parameters.
Abdom Radiol (NY)
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546828
16.
Exploring the Clinical Use of Molecular Profiling of Intrahepatic Cholangiocarcinoma in a Comprehensive Multidisciplinary Clinic.
J Am Coll Surg
; 238(4): 532-540, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38189646
17.
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial.
Nat Med
; 30(4): 1044-1053, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38584166
18.
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.
Cancer Res Commun
; 4(4): 1100-1110, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551394
19.
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.
J Clin Oncol
; 42(15): 1830-1850, 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502889
20.
DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma.
Cell Rep Med
; 5(3): 101469, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38508137